New publication led by Tanushree Haldar validates key genetic variants for statin muscle toxicity that, if applied clinically, will benefit understudied patient groups

We have published important findings that could improve statin safety for historically understudied populations. The study is titled SLCO1B1 Functional Variants, Bilirubin, Statin-Induced Myotoxicity, and Recent Sub-Saharan African Ancestry: A Precision Medicine Health Equity Study and it was published in Clinical Pharmacology & Therapeutics. Check it out!